Your SlideShare is downloading. ×
Business Plan Bps Cardiac Mc Combs School Of Business March 26 2010
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Business Plan Bps Cardiac Mc Combs School Of Business March 26 2010

2,662
views

Published on

Business Plan Bps Cardiac Mc Combs School Of Business March 26 2010

Business Plan Bps Cardiac Mc Combs School Of Business March 26 2010

Published in: Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,662
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
17
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. THE UNIVERSITY OF TEXAS AT AUSTIN
    BPS-Cardiac Medical Device:
    ChimeraTeam:
    Michele Gonzalez
    Viridiana Omana
    Marco Sanchez
    Fernando Huerta
    Business Plan Competition:
    MSTC Monterrey Program
    McCombs School of Business
    March 26th, 2010
  • 2. BPS-Cardiac: Presentation
    Pain
    Patient
    &
    StakeHolders
    ValueProposition &
    Technology
    MarketOpportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 3. BPS-Cardiac: Presentation
    Pain
    Patient
    &
    StakeHolders
    ValueProposition
    & Technology
    MarketOpportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 4. Did You Know?
    “Hearth blood pressure is highly related to Cardiac diseases and cause 7 million deaths worldwide” – WHO report.
    “Worldwide 418,000 persons die every year because of hearth strokes” – WHO report.
  • 5. PAIN: Blood Pressure methods.(Background)
    Central Venous Blood Pressure:
    Procedure: Measured inside the thoracic cava vena near the right atrium via catheterization.
    Goal: Identify problems related ability of the hearth to pump blood during trauma, hearth stroke in emergency rooms and/or ICU or ER.
    Method: Continuously / Accurate.
    External Venous Blood Pressure:
    • Procedure: Measured externally via a device or with an stethoscope.
    • 6. Goal: Register the External venous Blood pressure by event it helps to identify at given moment of time how the blood is flowing.
    • 7. Method:by event / Best effort.
  • PAIN: Circumstances
    People who experience a:
    Heart attack
    Intensive Care Units
    Trauma
    To save their lives….is critical to measure the Central Venous Pressure
  • 8. PAIN: Cardiac Catheterization
    Time Comsuming
    Painful
    Risky
    Expensive
  • 9. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 10. Patient & Stakeholders Analysis
    Stake Holder
    Patient and his Family
    Physician & Nurse
    Payers (Public & Private)
    Hospitals
    Government Regulator
    Needs & Concerns related to CVBP
    Pain and suffering
    Lawsuitsfor wrong catheterizations
    Cost of the procedure
    Facilities,Lawsuits, Productivity, Reputation
    Secure and effective treatments (Law/Reg.)
  • 11. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 12. Value Proposition
    A non invasive, painless, low cost, easy to use technology to measure Central Venous Blood Pressure (CVBP) to save peoples lives.
  • 13. Value Proposition: The Technology
    A disruptive non-invasive technology that measure through a sensor the mechanical activity of CVBP
  • 14. Technology: Good News!!
    A full functional Prototype is ready!!
  • 15. Technology Applications
    (+)
    Market Size (Units)
    (-)
    (+)
    (+)
    ICU
    Hospital Rooms.
    Price
    Margin %
    Doctors Office
    Home
    Personal
    (-)
    (-)
    (-)
    Precision
    (+)
  • 16. Technology: Current IP Status
    Mexico
    Filing: Ago ‘09
    Inventor: Teodoro Cordova, PhD
    Owner: Guanajuato University
    Testing: Lab and field testing already conducted
    COFEPRIS approval: Pending
  • 17. Technology Competitiveness
  • 18. Technology Competitiveness
  • 19. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 20. Market Opportunity ICU– US
    Total Market
    Equipment: Device Manufacturer
    58K units.
    $232 MUSD Revenues
    Procedures: Hospitals
    408K procedures.
    $3.2 BUSD
    Catheterization CVP
    (0.4M)
    Catheterization
    (1.2M)
  • 21. Market Opportunity ICU– Mexico
    Total Market
    Equipment: (Device Manufacturer)
    4K units.
    $16 MUSD Revenues
    Procedures: (Hospitals)
    40K procedures.
    $120 MUSD
    Catheterization CVP
    (40K)
    Catheterization
    (120K)
  • 22. Medical Devices – Hot Deal
    VC investment in Medical Devices Startups $719MUSD / Q4 2009
    Med. Devices
  • 23. Medical Devices – Hot Deal
    Medical Device Startups had raised from $64M usd to $1M usd
  • 24. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 25. Business Model Options
  • 26. Business Model Options
  • 27. Business Model
    Goal: License the technology to a major Medical Device Manufacturer
    GE Medical Systems
    Johnson & Johnson Medical System
    Baxter
    Etc.
  • 28. Business Model: Where we add value?
    Disruptive Technology
    Patent
    Exclusivity for US/Mexico Markets
    Regulatory Compliance
    Paperwork
    USPTO, FDA, COFEPRIS
    Clinical trials
    Manufacturing & Testing (1,000 Units)
  • 29. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 30. MANAGEMENT TEAM
    CEO & CFO
    Fernando Huerta
    (Innovation/ Telecom Consultant)
    Tec de Monterrey MBA
    Chief Marketing Officer
    Michele Gonzalez
    (Mexico City Technology Council)
    Master in Science IPN
    Regulatory & Oper. Officer
    Viridiana Omana
    (IT Tecnológico de Celaya)
    Computer Science
    Chief Technology Officer
    Marco Sanchez
    Guanajuato University
    Computer Science Tec de Monterrey
  • 31. Operational Plan: Timeline
    EXIT STRATEGY: Licensing the technology to a Medical DeviceManufacturer
    2012
    2011
    Conducting Clinical Trials to Hospitasl and R&D Centers
    Medical Device Manufacturer Start the Commercialization phase
    Manufacturing 1000 EQUIPMENTS
    COFEPRIS /FDA APROVALS/USPTO
    $
    8yrs Time Frame (2010-2017)
  • 32. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 33. Funds Required
    $ 1.57 MUSD
    Equity: 30%
    Funds used for:
    a) Exclusivity (US/Mex)
    b) FDA/COFEPRIS Approvals
    c) USPTO filing
    d) Clinical Trials
    e) Manufacturer 1,000 units
    f) Due diligence for contracting MDM
    Exit: Selling IP to a major Medical
    Device Manufacturer.
  • 34. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 35. Capital Structure
  • 36. BPS-Cardiac: Presentation
    Pain
    Value Proposition &
    Technology
    Patient
    &
    StakeHolders
    Market Opportunity
    Business Model
    Operational
    Plan
    Funds Required
    Capital Structure
    Financials
  • 37. Financials: Value Creation
    Investors & Founders: $8.9M usd
    Investors: 2.9 M usd
    Founders: $6.0M usd
    Medical Device Manufacturer: $14.1M usd
    High Margin Product:
    Price per Unit: $4,000
    Cost: $80 USD
    Sales Channel: Commission 28%
  • 38. Financials: Cost & Expenses
    Assumptions (Total Revenues 2010-2012 MUSD)
    Regulatory: USPTO/COFEPRIS/FDA: $0.60
    Clinical Trials $0.60
    IP Lawyers $0.30
    Deal Lawyers $0.30
    Headcount, Travel & Office Expenses $0.30
    Insurances $0.30
    Manufacturing 1,000 units $0.10
    Exclusivity fee Guanajuato University: $ 0.08
    Manufacturing 1,000 units $0.10
  • 39. BPS Cardiac: Remember!!!!!!
    This is an Excellent Opportunity to invest in a non-invasive low risk disruptive technology that saves people lives.
    Business Upsides: More applications, can be expanded worldwide and with a potential of developing a recurrent business disposals.
    That requires an investment of $1.57 MUSD used for: Clinical trials, Lawyers, Regulatory fee, manufacturing 1,000 units, insurance, due diligence with a major device manufacturing.
    And creates a value of $23M usd for investor, founders and the Device Manufacturer.
  • 40. BPS-Cardiac: Presentation
    Thanks!!!
    We are ready for Q&A
  • 41. THE UNIVERSITY OF TEXAS AT AUSTIN
    BPS-Cardiac Medical Device:
    ChimeraTeam:
    Michele Gonzalez
    Viridiana Omana
    Marco Sanchez
    Fernando Huerta
    Business Plan Competition:
    MSTC Monterrey Program
    McCombs School of Business
    March 26th, 2010